Skip to main content

June 2015

academics

 

Clinical research courses

There has been a 16 per cent increase in daily generation of bio-medical waste in 2012-13 as against a marginal increase of 0.33 per cent the year ago, Lok Sabha was informed. Karnataka was the highest producer of bio-waste at 83,614 kg per day, followed by Maharashtra, which produced 65,660 kg of bio-wastes every day.

Computer based recruitment test for post of Drug Inspectors (Total- 154 posts) by UPSC

ADDENDUM – NOTICE TO CANDIDATES:

Walk in interview for Pharmacists (30 Posts) in Kolkata City NUHM Society

Applications are invited from citizen of India for engagement of Pharmacists and (c) 60 (sixty) on contractual basis for 30 Urban Primary Health Centres in Kolkata City area under Kolkata City NUHM Society.

Post: Pharmacists

Opportunity for B.Pharm/ M.Pharm as Regional Sales Manager in IDPL

IDPL is the largest Central Pharma Public Sector Undertaking in India with plants at Rishikesh, Gurgaon & Hyderabad and two Subsidiary Units at Chennai and Muzaffarpur.
The vision of first Prime Minister of India, Late Pt. Jawahar Lal Nehru regarding Indian Drug Industry was that “the drug industry must be in the public sector….. I think an industry of the nature of the drug industry should not be in the private sector anyhow. There are for too much exploitation of the public in this industry”. With the vision of the then Prime Minister of India, IDPL was incorporated in April, 1961 (Company Registration No. 3418 of 1961-1962 with Registrar of Companies, Delhi and having its Registered and Corporate Office at Gurgaon) with main objectives of creating self-sufficiency in respect of essential life saving medicines, to free the country from dependence on imports and to provide medicines to the millions at affordable prices and not to make millions from the medicines. IDPL was basically conceived and established as a part of Healthcare Infrastructure and has played a pioneering infra-structural role in the growth of Indian Drug Industry base.

Post: Regional Sales Manager- 1- RSO, Delhi Zone

Career as Medical Repersentative (5 Opening) in Apple Therapeutics

Apple Therapeutics is a specialty pharmaceutical company marketing products to defined customer groups (specialty doctors), where effective targeting of prescribers allows maximization of sales by a relatively small but high quality sales force. Backed by a strong distribution network and extensive manufacturing and commercial skills, we strive to provide integrated healthcare solutions at affordable costs. Apple Therapeutics is amongst India’s fastest growing dermatology & trichology companies.

Post: Medical Repersentative

Opening for SENIOR PROJECT FELLOW (MEDICAL DEVICES) in HLL Lifecare

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: SENIOR PROJECT FELLOW (MEDICAL DEVICES)

In the United States every year nearly 90,000 women are diagnosed with some gynecological cancer. These include cancer of the cervix, uterus, ovaries, vagina, and vulva. These women undergo treatments including radiation, chemotherapy and surgery. A University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2015  has shown sexual dysfunction in women following gynecologic cancer treatment. The study shows decreased sexual activity in women following treatment for gynecologic cancers, down from 6.1-6.8 times per month before treatment to 2.6-4.9 times per month after treatment.

(adsbygoogle = window.adsbygoogle || []).push({});

Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.,  has received the 2015 Industry Innovation Award from the National Organization of Rare Disorders (NORD) in recognition of company's work in developing Hetlioz (tasimelteon) for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).  This award was presented to Vanda at the 2015 Portraits of Courage Gala in Washington D.C. on 18th May.

Merozyne Therapeutics AB has started a project goal to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A) by exploiting the unique research conducted by Prof. Madeleine Durbeej-Hjalt and Dr Virginie Carmignac at Lund University.

US Food and Drug Administration (FDA) has approved Eli Lilly and Company Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), a pre-filled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog (insulin lispro 100 units/mL) Humalog U-200 KwikPen is used to improve glycemic control in people with type 1 and type 2 diabetes.